125 related articles for article (PubMed ID: 37961863)
41. Based on Network Pharmacology to Explore the Molecular Targets and Mechanisms of Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis.
Wei M; Li H; Li Q; Qiao Y; Ma Q; Xie R; Wang R; Liu Y; Wei C; Li B; Zheng C; Sun B; Yu B
Biomed Res Int; 2020; 2020():5217405. PubMed ID: 33299870
[TBL] [Abstract][Full Text] [Related]
42. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
[TBL] [Abstract][Full Text] [Related]
43. Effective materials and mechanisms study of Tibetan herbal medicine Lagotis integra W. W. Smith treating DSS-induced ulcerative colitis based on network pharmacology, molecular docking and experimental validation.
Wang X; Zhang C; Liu L; Zhong Y; Wang Y; Liu F; Zhu J; Mu Z; Zhang S; Wang X; Zhong G; Liang J; Zeng J
J Ethnopharmacol; 2023 Jan; 301():115800. PubMed ID: 36228890
[TBL] [Abstract][Full Text] [Related]
44. Exploring the Potential Mechanism of Action of Ursolic Acid against Gastric Cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
[TBL] [Abstract][Full Text] [Related]
45. Identification of shared gene signatures and molecular mechanisms between chronic kidney disease and ulcerative colitis.
Liang Z; Hu X; Lin R; Tang Z; Ye Z; Mao R; Chen W; Zhou Y
Front Immunol; 2023; 14():1078310. PubMed ID: 36860851
[TBL] [Abstract][Full Text] [Related]
46. [Mechanism of Wuling Capsules against hepatic fibrosis based on network pharmacology and animal experiments].
Li N; Ren SJ; Zhou R; Song ZX; Liu YR; Tang ZS; Zhou JP; Cao ZJ
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5365-5376. PubMed ID: 38114126
[TBL] [Abstract][Full Text] [Related]
47. Exploring the Potential Mechanism of Xiaokui Jiedu Decoction for Ulcerative Colitis Based on Network Pharmacology and Molecular Docking.
Wang B; Liu Y; Sun J; Zhang N; Zheng X; Liu Q
J Healthc Eng; 2021; 2021():1536337. PubMed ID: 34733451
[TBL] [Abstract][Full Text] [Related]
48. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.
Shu W; Wang Z; Zhao R; Shi R; Zhang J; Zhang W; Wang H
Drug Des Devel Ther; 2022; 16():1847-1863. PubMed ID: 35734366
[TBL] [Abstract][Full Text] [Related]
49. Network pharmacology-based strategy to investigate the effect and mechanism of α-solanine against glioma.
Wang C; Liu X; Guo S
BMC Complement Med Ther; 2023 Oct; 23(1):371. PubMed ID: 37865727
[TBL] [Abstract][Full Text] [Related]
50. Investigation of the active ingredients and mechanism of Shuangling extract in dextran sulfate sodium salt induced ulcerative colitis mice based on network pharmacology and experimental verification.
Mengzhen C; Yu W; Zhijian L; Jintao L; Xiaomeng Z; Bing Z
J Tradit Chin Med; 2024 Jun; 44(3):478-488. PubMed ID: 38767631
[TBL] [Abstract][Full Text] [Related]
51. Stepwise tracking strategy to screen ingredient from Galla Chinensis based on the "mass spectrometry guided preparative chromatography coupled with systems pharmacology".
Wang Z; Xue R; Lv M; Qi Y; Yu W; Xie Z; Chen W; Wang X; Tian X; Han B
J Ethnopharmacol; 2022 Feb; 284():114533. PubMed ID: 34728319
[TBL] [Abstract][Full Text] [Related]
52. Network pharmacology dissection of multiscale mechanisms for jiaoqi powder in treating ulcerative colitis.
Wen S; Zhong Z; He L; Zhao D; Chen X; Mi H; Liu F
J Ethnopharmacol; 2021 Jul; 275():114109. PubMed ID: 33845143
[TBL] [Abstract][Full Text] [Related]
53. Banxia Xiexin decoction ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis via inhibiting serine-threonine protein kinase (Akt)/mitogen-activated protein kinase (MAPK) signaling pathway.
Ji W; Liu W; Huo Y; Hu C; Zhang Y
Biotechnol Appl Biochem; 2023 Aug; 70(4):1530-1542. PubMed ID: 36806191
[TBL] [Abstract][Full Text] [Related]
54. Identifying the Mechanisms and Molecular Targets of Guchang Zhixie Pills on Ulcerative Colitis: Coupling Network Pharmacology with GEO Database and Experiment Verification.
Wang W; Song X; Ding S; Chen C; Ma H
Comb Chem High Throughput Screen; 2023; 26(11):2039-2056. PubMed ID: 36597607
[TBL] [Abstract][Full Text] [Related]
55. [Mechanism of Zhongfeng Xingnao Decoction in improving microcirculatory disorders in cerebral hemorrhage based on network pharmacology and molecular docking techniques].
Zhong XQ; Hu DF; Wang Y; Ning ZQ; Deng MZ
Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6115-6127. PubMed ID: 38114219
[TBL] [Abstract][Full Text] [Related]
56. Uncovering the mechanism of Ge-Gen-Qin-Lian decoction for treating ulcerative colitis based on network pharmacology and molecular docking verification.
Xu L; Zhang J; Wang Y; Zhang Z; Wang F; Tang X
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33409535
[TBL] [Abstract][Full Text] [Related]
57. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma.
Zhou K; Lu D; You J; Liu T; Sun J; Lu Y; Pan J; Li Y; Liu C
J Ethnopharmacol; 2022 Nov; 298():115624. PubMed ID: 35970314
[TBL] [Abstract][Full Text] [Related]
58. Network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis.
Cai T; Cai B
Medicine (Baltimore); 2023 Nov; 102(45):e35852. PubMed ID: 37960728
[TBL] [Abstract][Full Text] [Related]
59. Common mechanisms of Wumei pills in treating ulcerative colitis and type 2 diabetes: Exploring an integrative approach through network pharmacology.
Sun C; Xiao K; He Y; Li X
Medicine (Baltimore); 2024 Jan; 103(4):e37094. PubMed ID: 38277529
[TBL] [Abstract][Full Text] [Related]
60. The Glabridin from Huangqin Decoction Prevents the Development of Ulcerative Colitis into Colitis-Associated Colorectal Cancer by Modulating MMP1/MMP3 Activity.
Li R; Chi H; Liao X; Cen S; Zou Y
Int Immunopharmacol; 2024 Jun; 135():112262. PubMed ID: 38805906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
